Viral Vector manufacturing market is expected to register a CAGR of +20% during the forecast period 2018 to 2023
Pune, India -- (SBWIRE) -- 08/10/2018 -- Viral vectors are highly valued to transfer genetic material into target cells and therefore are explored as vehicles in diverse therapeutic areas. Part of the enthusiasm of the scientific community for vectors is their promise of low cost and safe manufacturing coupled to high product efficacy and excellent safety. Engineered via molecular biology, viral vectors from well-studied natural viruses have been engineered including adenoassociated virus (AAV), lentivirus, adenovirus, or Modified Vaccinia Ankara (MVA) and have been explored for several decades now. Vectors are predominantly used to carry desired genetic material into cells or tissues with the purpose to correct genetic deficiencies or elicit host immune responses against either self-antigens (cancer) or foreign antigens (microbial, parasitic or viral pathogens).
The research report comprises key growth drivers and barriers of the Global Viral Vector manufacturing market, including their impact on production and demand in the next few years. In addition, the study includes a detailed analysis of the potential opportunities in the Global Viral Vector manufacturing market. It further includes the market attractiveness analysis, in which the product segments are studied based on growth rate, market size, and general attractiveness.
Get Sample PDF Pages:
Top Key Vendors:
Lonza (Switzerland), Merck (Germany), Oxford BioMedica (UK), CGT Catapult (UK), Cobra Biologics (UK), uniQure (Netherlands), FUJIFILM Diosynth Biotechnologies (US), Kaneka Eurogentec (Japan), and Spark Therapeutics (US).
Based on application, the global Viral Vector manufacturing Market is segmented into gene therapy and vaccinology. In 2018, the gene therapy segment is expected to hold the largest share in this market and this segment is also expected to grow at the highest rate during the forecast period. The large share and fast growth of this segment can be attributed to the large number of clinical trials conducted for gene therapy on target diseases such as cancer, neurodegenerative diseases, and cardiovascular diseases globally.
Furthermore, the major geographical segments of the Global Viral Vector manufacturing market have been evaluated in the research report. The market share, consumption, revenue, and size of each segment have been provided in the study. A list of all the prominent players operating in the Viral Vector manufacturing market across the globe has been presented along with detailed company profiles and major developments.
To get more information, Ask for Sample PDF illustration with TOC, Tables, Figures and Charts @
Table Of Content:
Chapter 1 Industry Overview of Viral Vector manufacturing
Chapter 2 Manufacturing Cost Structure Analysis of Viral Vector manufacturing
Chapter 3 Technical Data and Manufacturing Plants Analysis of Viral Vector manufacturing
Chapter 4 Global Viral Vector manufacturing Overall Market Overview
Chapter 5 Viral Vector manufacturing Regional Market Analysis
Chapter 6 Major Manufacturers Analysis of Viral Vector manufacturing
Chapter 7 Development Trend of Analysis of Viral Vector manufacturing Market
Chapter 8 Viral Vector manufacturing Marketing Type Analysis
Chapter 9 Conclusion of the Global Viral Vector manufacturing Market Professional Survey Report 2018
Early buyers will receive up to 40% Discount on this report